slotkoers
Taipei Exchange
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
35,65
TWD
|
+0,85%
|
|
+0,85%
|
-10,20%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
586,9
|
694,9
|
1.102
|
826,3
|
1.528
|
1.682
|
Bedrijfswaarde
1 |
621,7
|
718,5
|
1.307
|
1.001
|
1.598
|
1.710
|
K/w-verhouding
|
-39,2
x
|
22,2
x
|
36,1
x
|
139
x
|
21,8
x
|
27
x
|
Dividendrendement
|
-
|
-
|
0,38%
|
0,51%
|
2,22%
|
2,02%
|
Marktkapitalisatie/omzet
|
1,64
x
|
1,67
x
|
2,38
x
|
1,73
x
|
2,69
x
|
3,01
x
|
Bedrijfswaarde/omzet
|
1,74
x
|
1,72
x
|
2,82
x
|
2,1
x
|
2,82
x
|
3,06
x
|
Bedrijfswaarde/EBITDA
|
22,1
x
|
12
x
|
19,8
x
|
21,5
x
|
18,6
x
|
19,1
x
|
Bedrijfswaarde/FCF
|
-1.604
x
|
475
x
|
-127
x
|
24,6
x
|
48,5
x
|
35,8
x
|
FCF Yield
|
-0,06%
|
0,21%
|
-0,79%
|
4,06%
|
2,06%
|
2,79%
|
Price to Book
|
1,32
x
|
1,39
x
|
2,15
x
|
1,61
x
|
2,49
x
|
2,65
x
|
Aantal aandelen (in duizenden)
|
42.373
|
42.373
|
42.373
|
42.373
|
42.373
|
42.373
|
Referentieprijs
2 |
13,85
|
16,40
|
26,00
|
19,50
|
36,05
|
39,70
|
Datum van publicatie
|
29/03/19
|
27/03/20
|
23/03/21
|
7/03/22
|
16/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
357,1
|
416,8
|
463,2
|
477,6
|
567,3
|
559,2
|
EBITDA
1 |
28,07
|
60,12
|
65,9
|
46,47
|
85,94
|
89,63
|
Bedrijfsresultaat (EBIT)
1 |
-21,82
|
21,92
|
29,41
|
7,215
|
48,71
|
55,98
|
Operationele Marge
|
-6,11%
|
5,26%
|
6,35%
|
1,51%
|
8,59%
|
10,01%
|
Resultaat voor belastingen (EBT)
1 |
-16,84
|
31,32
|
28,36
|
6,806
|
75,56
|
67,74
|
Nettowinst (verlies)
1 |
-14,96
|
31,32
|
30,74
|
6,004
|
69,99
|
62,51
|
Nettomarge
|
-4,19%
|
7,51%
|
6,64%
|
1,26%
|
12,34%
|
11,18%
|
WPA
2 |
-0,3530
|
0,7391
|
0,7200
|
0,1400
|
1,650
|
1,470
|
Free Cash Flow
1 |
-0,3875
|
1,513
|
-10,26
|
40,68
|
32,93
|
47,74
|
FCF-marge
|
-0,11%
|
0,36%
|
-2,22%
|
8,52%
|
5,81%
|
8,54%
|
Kasstroomconversie (ebitda)
|
-
|
2,52%
|
-
|
87,54%
|
38,32%
|
53,26%
|
Kasstroomconversie (nettowinst)
|
-
|
4,83%
|
-
|
677,49%
|
47,05%
|
76,38%
|
Dividend per aandeel
|
-
|
-
|
0,1000
|
0,1000
|
0,8000
|
0,8000
|
Datum van publicatie
|
29/03/19
|
27/03/20
|
23/03/21
|
7/03/22
|
16/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
34,8
|
23,6
|
205
|
174
|
70,1
|
28,2
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
1,241
x
|
0,3918
x
|
3,114
x
|
3,753
x
|
0,8158
x
|
0,3144
x
|
Free Cash Flow
1 |
-0,39
|
1,51
|
-10,3
|
40,7
|
32,9
|
47,7
|
ROE (netto-inkomsten/eigen vermogen)
|
-3,42%
|
6,62%
|
5,58%
|
1,4%
|
12,1%
|
9,58%
|
ROA (netto-inkomsten/totale activa)
|
-2,34%
|
2,11%
|
2,24%
|
0,48%
|
3,11%
|
3,47%
|
Totale activa
1 |
638,5
|
1.484
|
1.371
|
1.254
|
2.251
|
1.803
|
Nettoactief per aandeel
2 |
10,50
|
11,80
|
12,10
|
12,10
|
14,50
|
15,00
|
Cashflow per aandeel
2 |
0,9500
|
1,250
|
1,260
|
1,850
|
3,400
|
2,930
|
Capex
1 |
15,5
|
14,7
|
39,4
|
27,2
|
26,2
|
27,5
|
Capex/omzet
|
4,33%
|
3,52%
|
8,5%
|
5,69%
|
4,61%
|
4,91%
|
Datum van publicatie
|
29/03/19
|
27/03/20
|
23/03/21
|
7/03/22
|
16/03/23
|
14/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,20% | 46,45 mln. | | +40,73% | 739 mld. | | +32,83% | 598 mld. | | -6,30% | 353 mld. | | +15,15% | 318 mld. | | +4,05% | 285 mld. | | +15,00% | 240 mld. | | -5,52% | 206 mld. | | +6,17% | 164 mld. | | -0,45% | 162 mld. |
Farmaceutische producten - Andere
|